Notice: This company has been marked as potentially delisted and may not be actively trading. TradeUP Acquisition (UPTD) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends UPTD vs. BCDA, KLTO, BCLI, COEP, CERO, EVAX, ONVO, FRTX, ALBT, and CELZShould you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include BioCardia (BCDA), Klotho Neurosciences (KLTO), Brainstorm Cell Therapeutics (BCLI), Coeptis Therapeutics (COEP), CERo Therapeutics (CERO), Evaxion Biotech A/S (EVAX), Organovo (ONVO), Fresh Tracks Therapeutics (FRTX), Avalon GloboCare (ALBT), and Creative Medical Technology (CELZ). These companies are all part of the "biological products, except diagnostic" industry. TradeUP Acquisition vs. BioCardia Klotho Neurosciences Brainstorm Cell Therapeutics Coeptis Therapeutics CERo Therapeutics Evaxion Biotech A/S Organovo Fresh Tracks Therapeutics Avalon GloboCare Creative Medical Technology TradeUP Acquisition (NASDAQ:UPTD) and BioCardia (NASDAQ:BCDA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, community ranking, risk, media sentiment and profitability. Which has preferable valuation and earnings, UPTD or BCDA? TradeUP Acquisition has higher earnings, but lower revenue than BioCardia. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTradeUP AcquisitionN/AN/A-$1MN/AN/ABioCardia$71K127.19-$11.57M-$4.19-0.47 Which has more volatility and risk, UPTD or BCDA? TradeUP Acquisition has a beta of 0.12, suggesting that its stock price is 88% less volatile than the S&P 500. Comparatively, BioCardia has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Does the MarketBeat Community believe in UPTD or BCDA? BioCardia received 16 more outperform votes than TradeUP Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformTradeUP AcquisitionN/AN/ABioCardiaOutperform Votes1659.26% Underperform Votes1140.74% Do analysts rate UPTD or BCDA? BioCardia has a consensus target price of $25.00, indicating a potential upside of 1,169.04%. Given BioCardia's stronger consensus rating and higher possible upside, analysts clearly believe BioCardia is more favorable than TradeUP Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TradeUP Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00BioCardia 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer UPTD or BCDA? In the previous week, BioCardia had 5 more articles in the media than TradeUP Acquisition. MarketBeat recorded 5 mentions for BioCardia and 0 mentions for TradeUP Acquisition. TradeUP Acquisition's average media sentiment score of 0.67 beat BioCardia's score of 0.58 indicating that TradeUP Acquisition is being referred to more favorably in the media. Company Overall Sentiment TradeUP Acquisition Positive BioCardia Positive Do insiders & institutionals have more ownership in UPTD or BCDA? 35.0% of TradeUP Acquisition shares are held by institutional investors. Comparatively, 20.6% of BioCardia shares are held by institutional investors. 55.1% of TradeUP Acquisition shares are held by insiders. Comparatively, 20.0% of BioCardia shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is UPTD or BCDA more profitable? TradeUP Acquisition has a net margin of 0.00% compared to BioCardia's net margin of -1,999.77%. Company Net Margins Return on Equity Return on Assets TradeUP AcquisitionN/A N/A -3.38% BioCardia -1,999.77%N/A -208.38% SummaryBioCardia beats TradeUP Acquisition on 7 of the 13 factors compared between the two stocks. Ad Stansberry Research$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now. Get TradeUP Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for UPTD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPTD vs. The Competition Export to ExcelMetricTradeUP AcquisitionBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.52M$2.94B$5.14B$9.08BDividend YieldN/A1.90%5.09%4.23%P/E RatioN/A46.7390.0517.18Price / SalesN/A415.011,116.25117.05Price / CashN/A182.1043.1037.85Price / Book-0.733.894.784.78Net Income-$1M-$42.21M$120.31M$225.60M TradeUP Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPTDTradeUP AcquisitionN/A$1.16+5.5%N/A-6.5%$2.52MN/A0.002,021Gap DownBCDABioCardia3.3081 of 5 stars$2.09+0.5%$25.00+1,096.2%-79.8%$9.58M$71,000.00-0.5016Analyst ForecastShort Interest ↓Positive NewsGap UpKLTOKlotho NeurosciencesN/A$0.44+3.1%N/AN/A$9.43MN/A0.00N/AGap DownBCLIBrainstorm Cell Therapeutics3.993 of 5 stars$1.55+6.9%$30.00+1,835.5%-21.2%$8.84MN/A-0.3040Gap UpCOEPCoeptis Therapeutics0.3751 of 5 stars$0.19+5.5%N/A-83.9%$7.85M$80,000.00-0.612Gap UpCEROCERo TherapeuticsN/A$0.05-10.1%N/AN/A$7.67MN/A0.008High Trading VolumeEVAXEvaxion Biotech A/S3.1513 of 5 stars$1.05-7.9%$11.00+947.6%-86.6%$6.16M$3.30M-3.4849ONVOOrganovoN/A$0.39-3.6%N/A-67.6%$5.99M$110,000.000.0020Analyst ForecastFRTXFresh Tracks TherapeuticsN/A$0.75flatN/A-9.8%$4.48M$10.06M-0.5320ALBTAvalon GloboCare0.3359 of 5 stars$3.86-16.1%N/A-55.4%$4.22M$1.31M-0.215CELZCreative Medical Technology0.5925 of 5 stars$2.32+5.9%N/A-55.2%$4.06M$11,000.00-0.615Positive News Related Companies and Tools Related Companies BioCardia Alternatives Klotho Neurosciences Alternatives Brainstorm Cell Therapeutics Alternatives Coeptis Therapeutics Alternatives CERo Therapeutics Alternatives Evaxion Biotech A/S Alternatives Organovo Alternatives Fresh Tracks Therapeutics Alternatives Avalon GloboCare Alternatives Creative Medical Technology Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:UPTD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TradeUP Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share TradeUP Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UPTD Stock Alerts